Cargando…
FRI090 Patterns Of Triglyceride Testing And Results Over Time Among Patients With Diabetes And Severe Hypertriglyceridemia In US Clinical Practice
Disclosure: E. Kutrieb: Consulting Fee; Self; Ionis Pharmaceuticals Inc. S.J. Baum: Advisory Board Member; Self; Altimmune, Amgen Inc, Axcella, Boehringer Ingelheim, Eli Lilly & Company, Esperion, Madrigal Pharmaceuticals, Novartis Pharmaceuticals, Regeneron Pharmaceuticals. Consulting Fee; Self...
Autores principales: | Kutrieb, Emily, Baum, Seth J, Dukes, Ellen, Sikora Kessler, Asia, Weycker, Derek, Vera Llonch, Montserrat, Respress, Jonathan, Soffer, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555259/ http://dx.doi.org/10.1210/jendso/bvad114.604 |
Ejemplares similares
-
FRI089 Massive Hypertriglyceridemia? Think Oral Contraceptive Pills!
por: Ali, Israa, et al.
Publicado: (2023) -
FRI101 Marked Reduction In Severe Resistant Hypertriglyceridemia On PCSK9 Inhibitor
por: Kaul, Sabrina, et al.
Publicado: (2023) -
FRI093 Severe Hypertriglyceridemia Post Liver Transplant- A Multifactorial Disorder
por: Saand, Aisha R, et al.
Publicado: (2023) -
FRI095 Pseudo Anion Gap Metabolic Acidosis Secondary To Severe Hypertriglyceridemia
por: Connery, Grissim C, et al.
Publicado: (2023) -
Determination of the Optimal Cutoff Value of Triglyceride That Corresponds to Fasting Levels in Chinese Subjects With Marked Hypertriglyceridemia
por: Guo, Li-Ling, et al.
Publicado: (2021)